Monday, December 23, 2024
HomeTagsAbility Biologics

Ability Biologics

Ability Biologics Announces the Closing of its US $18 Million Seed Funding Extension toward the Generation of Novel, Highly Targeted Immunomodulators

Ability Biologics announced the final closing of its seed funding, raising a total of $18 million (US), a financing round led by founding investor Amplitude...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics